Truven

TriNetX is a global health research network that connects healthcare organizations and life sciences companies to drive real-world research and accelerate the development of new therapies. By leveraging a self-service, HIPAA, GDPR, and LGPD-compliant platform, TriNetX enables users to access federated electronic health records, datasets, and consulting partnerships. This empowers the worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. The network encompasses over 275 million patients from 150 healthcare organizations across 25 countries, providing a vast and diverse dataset for research. Researchers have utilized the TriNetX network to analyze more than 26,000 protocols and present over 7,000 clinical trial opportunities to its healthcare members, significantly reducing site identification time in clinical trials by 50%.

Based on proven medical science and explainable systems biology, DARA enables and enhances clinical decision support and intervention guidance. We work with healthcare providers and stakeholders to provide digital solutions that transform health screening and chronic disease management. We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices. We help physicians engage with patients better by providing actionable health insights through personalized disease risk and adverse event predictions. We guide pharmaceutical development by revealing pharmacodynamics in complex biological processes and find novel therapeutic interventions. Predictive analytics on multidimensional patient data will enable personalized precision medicine in the management of cardiometabolic disease to prevent catastrophic patient outcomes.